1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. PDS BIOTECHNOLOGY CORPORATION
PDS Biotechnology Corporation
XNAS: PDSB
Download real time
1.060.02(1.92%)
31.61% Fall from 52W High
5.5M
XNAS Volume

XNAS 07 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

PDS biotech Corp quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

PDS biotech Corp quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue PDS biotech Corp Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Quarterly Net Profit PDS biotech Corp Jun-2026 Quarterly Net Profit is $-10 Million which is growth of -3.4% YoY.

PDS Biotechnology Corporation, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
6.56.56.78.17.69.17.410.28.710.110.410.512.7
Operating Profit
-6.5-6.5-6.7-8.1-7.6-9.1-7.4-10.2-8.7-10.1-10.4-10.5-12.7
⌄
-3.3-0.8-0.9-0.9-1.8-0.6-0.6-0.6-0.5-0.5-0.5-0.3-0.2
Profit Before Tax
-9.8-7.4-7.6-9-9.4-9.7-8-10.7-9.2-10.6-10.9-10.9-12.9
Tax
-1.2-0.9--1.4
⌄
-9.8-7.4-7.6-9-9.4-8.5-8-10.7-8.3-10.6-10.9-10.9-11.5
Diluted NI Avail to Com Stockholders Ann.
-9.8-7.4-7.6-9-9.4-8.5-8-10.7-8.3-10.6-10.9-10.9-11.5
Basic EPS
-0.2-0.1-0.1-0.2-0.2-0.2-0.2-0.3-0.2-0.3-0.4-0.4-0.4
Diluted EPS After ExtraOrdinary
-0.2-0.1-0.1-0.2-0.2-0.2-0.2-0.3-0.2-0.3-0.4-0.4-0.4
Number Of Shares End
55.755.551.646.945.940.537.536.836.734.831.730.930.8
Net Income Continuing Discontinued Operations
-9.8-7.4-7.6-9-9.4-8.5-8-10.7-8.3-10.6-10.9-10.9-11.5
Normalized Income
-9.8-7.4-7.6-9-9.4-8.5-8-10.7-8.3-10.6-10.9-10.9-11.5
Interest Income
0.10.20.20.30.30.40.50.70.70.70.70.70.8
Interest
3.411.11.22.10.91.11.21.21.21.21.11
Net Interest Income
-3.3-0.8-0.9-0.9-1.8-0.6-0.6-0.6-0.5-0.5-0.5-0.3-0.2
EBIT
-6.4-6.3-6.5-7.9-7.3-8.7-6.9-9.5-8-9.4-9.7-9.8-12
EBITDA
-6.4-6.3-6.4-7.9-7.3-8.7-6.9-9.5-8-9.4-9.7-9.8-11.9
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
000000000
Profit From Continuing Operations
-9.8-7.4-7.6-9-9.4-8.5-8-10.7-8.3-10.6-10.9-10.9-11.5
Normalized EBITDA
-6.4-6.3-6.4-7.9-7.3-8.7-6.9-9.5-8-9.4-9.7-9.8-11.9
*All financials are in USD Million and price data in USD
Add metric to table
Search...

PDS biotech Corp competitor comparison and performance snapshot within industry

PDS biotech Corp annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Annual Revenue PDS biotech Corp Annual Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Annual Net Profit PDS biotech Corp Annual Net Profit is $-34 Million which is growth of 8.3% YoY.

PDS Biotechnology Corporation, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-
-
 
Cost Of Rev. Ann.
-
-
 -----------
Gross Profit Ann.
-
-
 -----------
Operating Exp. Ann.
-8.9%
16.2%
27.831.536.343.141.721.414.917.130.45239.526.5
Operating Profit Ann.
-
-
-27.8-31.5-36.3-43.1-41.7-21.4-14.9-17.1-30.4-52-39.5-26.5
⌄
-
-
-5.8-4.1-2.2-1.3-0.40.10.3-0.6-1.5-1-0.8
Other Exp. Ann.
-
-
 ------9.4-12.7--0.2-1.9
PBT Ann.
-
-
-33.7-35.7-38.5-44.4-42.1-21.4-14.9-7.4-43.7-53.5-40.7-29.2
Tax Ann.
-
-
 -1.2-0.9-1.4-1.2-4.5-0.4-2.8-2.6-1.9-1.1
⌄
-
-
-33.7-34.5-37.6-42.9-40.9-16.9-14.9-7-40.9-50.9-38.8-32.4
Diluted NI Avail to Com Stockholders Ann.
-
-
-33.7-34.5-37.6-42.9-40.9-16.9-14.9-7-40.9-50.9-38.8-32.4
EPS Ann.
-
-
 -0.7-1-1.4-1.4-0.7-0.9-1.4-26.2-33.4-26.8-80.2
Diluted EPS Ann.
-
-
 -0.7-1-1.4-1.4-0.7-0.9-1.4-26.2-33.4-26.8-80.2
Number Of Shares End
21.2%
18.3%
 51.637.531.72928.522.35.31.61.61.51.4
Total Exp. Ann.
-8.9%
16.2%
 31.536.343.141.721.414.917.130.45239.526.5
Net Income Continuing Discontinued Operations Ann.
-
-
-33.7-34.5-37.6-42.9-40.9-16.9-14.9-7-40.9-50.9-38.8-28.1
Normalized Income Ann.
-
-
-33.7-34.5-37.6-42.9-40.9-16.9-14.9-15.9-28.9-50.9-38.8-26.3
Interest Income Ann.
10.1%
64.4%
0.81.22.52.90.90.10.40.90.70.20
Interest Ann.
59.8%
-
6.75.34.74.21.3-01.42.21.20.8
EBITDA Ann.
-
-
-27-30.3-33.8-40.1-40.7-21.4-14.8-7.3-42.1-51.1-39.4-28.3
Reconciled Cost Of Rev. Ann.
-
-
 -----------
Reconciled Depr. Ann.
-
-
0000000.10.20.20.10.1
Profit From Continuing Operations Ann.
-
-
-33.7-34.5-37.6-42.9-40.9-16.9-14.9-7-40.9-50.9-38.8-28.1
Normalized EBITDA Ann.
-
-
-27-30.3-33.8-40.1-40.7-21.4-14.8-16.6-29.3-51.1-39.4-26.4
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
-13.2%
2Y CAGR
-14.5%
3Y CAGR
-8.9%
5Y CAGR
16.2%
7Y CAGR
0.5%
10Y CAGR
1.7%
Operating Expenses Annual Cr is falling faster than historical averages.

PDS biotech Corp balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund PDS biotech Corp Dec-2025 Total Shareholders Fund is $9 Million which is growth of -51.3% YoY.

  • NEGATIVE

    Total Assets PDS biotech Corp Dec-2025 Total Assets is $30 Million which is growth of -32.8% YoY.

PDS Biotechnology Corporation, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-26.6%
-0.3%
30.545.459.47767.230.914.536.292.6110.9134.1
⌄
-13.7%
41%
21.226.433.33343.82.86.430.321.611.6
⌄
-40.4%
-19.3%
9.31926.14463.227.111.729.862.489.3122.5
Total Capitalization Ann.
-32.1%
-5%
2128.245.66763.227.111.729.879.8104.2125.5
Tangible Assets Ann.
-40.4%
-19.3%
9.31926.14463.227.111.729.862.489.3122.5
Working Capital Ann.
-34.4%
-7.1%
18.82845.466.763.127.111.729.376.2100.7122.7
Invested Capital Ann.
-27%
-0.7%
26.140.749.86763.227.111.729.882.8104.2127.8
Tangible Book Value Ann.
-40.4%
-19.3%
9.31926.14463.227.111.729.862.489.3122.5
Borrowings Ann.
-10.4%
95%
16.921.823.923.50.50.6--20.5155.3
Net Debt Ann.
-
-
-----------
Share Issued Ann.
22%
19.7%
54.93833.130.228.522.35.31.61.51.51.4
Number Of Shares End
21.2%
18.3%
51.637.531.72928.522.35.31.61.61.51.4
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-32.8%
2Y CAGR
-28.3%
3Y CAGR
-26.6%
5Y CAGR
-0.3%
7Y CAGR
-2.4%
10Y CAGR
-13.8%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-44.4%
2Y CAGR
-16.4%
3Y CAGR
-1%
5Y CAGR
23.5%
7Y CAGR
5.8%
10Y CAGR
1%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-51.1%
2Y CAGR
-40.3%
3Y CAGR
-40.4%
5Y CAGR
-19.3%
7Y CAGR
-15.3%
10Y CAGR
-22.7%
Total ShareHolders Funds Annual is falling faster than historical averages.

PDS biotech Corp ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share PDS biotech Corp Book Value Per Share is $-0 which is growth of -118.9% YoY.

  • NEUTRAL

    ROE PDS biotech Corp ROE is 0% which is growth of 0% YoY.

PDS Biotechnology Corporation, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--71.81%-62.97%-56.66%-34.50%-65.43%-27.60%-63.44%-49.98%-31.69%-42.92%
ROE Ann. %
-
-
--166.65%-122.46%-76.21%-37.46%-76.48%-33.70%-88.64%-67.08%-36.67%-68.54%
ROIC %
-
-
--16.8-21.4-25.9-9.6-13.6-30.8-10.7-15.2-8.4-19
OPM Ann. %
-
-
-----------
Inventory Turnover Ratio Ann.
-
-
-----------
Asset Turnover Ann. %
-
-
-----------
Working Capital Turnover Ann.
-
-
Quick Ratio Ann.
-
-
-2.44.27.517.48.84.45.46.815.915.2
Current Ratio Ann.
-
-
-2.64.37.817.89.35.25.66.916.115.3
Interest Coverage Ratio Ann.
-
-
--7.2-9.5-30.9---218.9-29.6-23.5-32.8-34.8
LT Debt To Equity Ann.
-
-
-0.50.80.50--0.30.20
*All financials are in USD Million and price data in USD
Add metric to table
Search...

PDS biotech Corp cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity PDS biotech Corp Cash From Operating Activity is $-28 Million which is growth of 20.8% YoY.

  • NEGATIVE

    Net Cash Flow PDS biotech Corp Net Cash Flow is $-15 Million which is growth of -0.7% YoY.

PDS Biotechnology Corporation, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-
-
-27.8-35-33.6-25.7-12.5-13.2-18.1-33.2-40.7-32.2-21.8
⌄
-
-
-0---29.4-0.2-0.7-1.3
⌄
-28%
-15.6%
12.820.216.434.348.929.80.8-20.322.69.1139.5
Cash Plus Cash Eqv. End Of Year Ann.
-28.7%
-1.5%
26.741.756.673.865.228.812.234.788.1106.4130.2
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-15-14.9-17.38.636.416.712.1-53.4-18.3-23.8116.5
Cash Plus Cash Eqv. Begin Of Year Ann.
-13.8%
27.9%
41.756.673.865.228.812.20.188.1106.4130.213.7
Income Tax Paid Supplemental Data Ann.
-
-
---------
Interest Paid Supplemental Data Ann.
47.7%
-
2.93.63.50.9--1.11.60.80.6
Capex Ann.
-
-
--0-------0.2-0.7-1.3
Issuance Of Capital Stock Ann.
12.2%
-14%
1422.616.19.948.529.80.817.4138.5
Issuance Of Debt Ann.
-10%
-
18.2-25---5113
Repayment Of Debt Ann.
-
-
-25.7-3.2-0.1----20-1.5-0.5
Repurchase Of Capital Stock Ann.
-
-
----------
Free Cash Flow Ann.
-
-
-27.8-35.1-33.6-25.7-12.5-13.2-18.1-33.2-40.9-32.9-23.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
-36.6%
2Y CAGR
-11.7%
3Y CAGR
-28%
5Y CAGR
-15.6%
10Y CAGR
-21.2%
Cash from Financing Annual Activity is falling faster than historical averages.
×